24.04.2015 • NewsappointmentAstraZenecaCorden Pharma

Dr. Giorgio Bruno Appointed as New General Manager of Recipharm Italia

Dr. Giorgio Bruno has been appointed General Manager of Recipharm Italia. In this role, he will serve as CEO for all of Recipharm's Italian operating companies. Dr. Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. He has worked in both Italian and multinational pharmaceutical companies covering a wide range of disciplines. In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. Dr. Bruno also has held a number of positions within Italian based industry associations. He holds a Ph.D. in Pharmaceutical Chemistry and Technology from the University of Milan.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.